Portage Biotech (PRTG) Competitors $7.63 +0.67 (+9.63%) Closing price 09/3/2025Extended Trading$7.63 0.00 (0.00%) As of 09/3/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTG vs. ITRM, RVPH, RNTX, MAAQ, KZR, CASI, DARE, NEUP, AKTX, and TENXShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Iterum Therapeutics (ITRM), Reviva Pharmaceuticals (RVPH), Rein Therapeutics (RNTX), Mana Capital Acquisition (MAAQ), Kezar Life Sciences (KZR), CASI Pharmaceuticals (CASI), Dare Bioscience (DARE), Neuphoria Therapeutics (NEUP), Akari Therapeutics (AKTX), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Its Competitors Iterum Therapeutics Reviva Pharmaceuticals Rein Therapeutics Mana Capital Acquisition Kezar Life Sciences CASI Pharmaceuticals Dare Bioscience Neuphoria Therapeutics Akari Therapeutics Tenax Therapeutics Portage Biotech (NASDAQ:PRTG) and Iterum Therapeutics (NASDAQ:ITRM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends. Which has more volatility & risk, PRTG or ITRM? Portage Biotech has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Iterum Therapeutics has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500. Which has higher valuation & earnings, PRTG or ITRM? Iterum Therapeutics is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPortage BiotechN/AN/A-$6.77M-$41.65-0.18Iterum TherapeuticsN/AN/A-$24.77M-$0.85-0.80 Is PRTG or ITRM more profitable? Company Net Margins Return on Equity Return on Assets Portage BiotechN/A N/A N/A Iterum Therapeutics N/A N/A -65.01% Does the media refer more to PRTG or ITRM? In the previous week, Iterum Therapeutics had 1 more articles in the media than Portage Biotech. MarketBeat recorded 2 mentions for Iterum Therapeutics and 1 mentions for Portage Biotech. Iterum Therapeutics' average media sentiment score of 1.45 beat Portage Biotech's score of 0.95 indicating that Iterum Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Portage Biotech Positive Iterum Therapeutics Positive Do insiders & institutionals hold more shares of PRTG or ITRM? 13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 9.2% of Iterum Therapeutics shares are owned by institutional investors. 42.1% of Portage Biotech shares are owned by company insiders. Comparatively, 2.4% of Iterum Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend PRTG or ITRM? Iterum Therapeutics has a consensus price target of $9.00, suggesting a potential upside of 1,224.89%. Given Iterum Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Iterum Therapeutics is more favorable than Portage Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Iterum Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryIterum Therapeutics beats Portage Biotech on 7 of the 11 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.01M$3.08B$5.69B$10.27BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-0.1821.3075.8626.51Price / SalesN/A379.77489.92165.26Price / CashN/A44.4425.8129.89Price / Book-9.669.6112.846.32Net Income-$6.77M-$53.28M$3.28B$270.51M7 Day PerformanceN/A0.31%0.22%2.15%1 Month Performance-12.10%4.58%4.61%6.35%1 Year Performance94.64%9.24%68.33%25.48% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech0.6199 of 5 stars$7.63+9.6%N/A+114.3%$8.01MN/A-0.186Gap UpHigh Trading VolumeITRMIterum Therapeutics3.1459 of 5 stars$0.68+3.1%$9.00+1,221.6%-37.2%$31.98MN/A-0.8010Positive NewsShort Interest ↓RVPHReviva Pharmaceuticals2.8975 of 5 stars$0.45flat$5.20+1,063.3%-64.0%$30.33MN/A-0.695News CoverageAnalyst ForecastRNTXRein Therapeutics0.9811 of 5 stars$1.30-3.0%N/AN/A$30.30MN/A-0.489MAAQMana Capital AcquisitionN/A$3.71+0.6%N/A+1,169.3%$30.14MN/A0.001KZRKezar Life Sciences3.7418 of 5 stars$3.99-0.5%$9.00+125.5%-31.4%$29.21M$7M-0.4160Analyst UpgradeCASICASI Pharmaceuticals3.7933 of 5 stars$2.34-0.4%$4.00+70.9%-70.9%$28.79M$28.54M-0.81180DAREDare Bioscience2.7026 of 5 stars$2.13-0.2%$10.00+370.6%-38.7%$28.52M-$17.70K-0.9930Positive NewsShort Interest ↓NEUPNeuphoria Therapeutics2.5898 of 5 stars$14.83+14.2%$21.00+41.6%N/A$27.88M$10K0.00N/AAKTXAkari Therapeutics3.7079 of 5 stars$0.85flat$3.30+288.2%-76.2%$27.73MN/A0.009TENXTenax Therapeutics2.2281 of 5 stars$6.04flat$18.00+198.0%+59.8%$27.56MN/A-6.579News CoverageHigh Trading Volume Related Companies and Tools Related Companies Iterum Therapeutics Alternatives Reviva Pharmaceuticals Alternatives Rein Therapeutics Alternatives Mana Capital Acquisition Alternatives Kezar Life Sciences Alternatives CASI Pharmaceuticals Alternatives Dare Bioscience Alternatives Neuphoria Therapeutics Alternatives Akari Therapeutics Alternatives Tenax Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTG) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts